Medicinova (MNOV) Enterprise Value (2021 - 2025)
Medicinova (MNOV) has disclosed Enterprise Value for 8 consecutive years, with -$30.8 million as the latest value for Q4 2025.
- Quarterly Enterprise Value changed N/A to -$30.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$30.8 million through Dec 2025, changed N/A year-over-year, with the annual reading at -$30.8 million for FY2025, N/A changed from the prior year.
- Enterprise Value for Q4 2025 was -$30.8 million at Medicinova, up from -$32.6 million in the prior quarter.
- The five-year high for Enterprise Value was -$30.8 million in Q4 2025, with the low at -$77.8 million in Q2 2021.
- Average Enterprise Value over 5 years is -$53.6 million, with a median of -$52.0 million recorded in 2022.
- The sharpest move saw Enterprise Value soared 30.01% in 2022, then grew 1.9% in 2023.
- Over 5 years, Enterprise Value stood at -$71.4 million in 2021, then increased by 26.49% to -$52.5 million in 2022, then grew by 2.87% to -$51.0 million in 2023, then increased by 17.1% to -$42.3 million in 2024, then rose by 27.14% to -$30.8 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods came in at -$30.8 million, -$32.6 million, and -$34.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.